Polymédication et diabète : une réalité bénéfique ou nocive pour l'individu âgé?

 

Marie-Eve Gagnon

Université du Québec à Rimouski (UQAR)

 

Domaine : Vieillissement

Programme : Formation de maîtrise pour les détenteurs d'un diplôme professionnel

Concours 2016-2017

Partenaire:

Unité SOUTIEN du Québec (Stratégie de recherche axée sur le patient)

About a quarter of older individuals in Quebec suffer from diabetes. As they also often suffer from several other diseases concomitantly, the number of medications they used is elevated. Polypharmacy has been associated with a greater risk of being exposed to inappropriate medications. Nonetheless, there is little information on the actual situation regarding the inappropriate or unwarranted use of medications among older individuals with diabetes in Quebec.

The aim of the project is to determine the proportion of older individuals with diabetes in Quebec that 1) receive an optimal treatment of diabetes, and 2) receive inappropriate medications. We will assess whether or not the quality of the therapy is associated with the number of drugs being used.

We will use the data of the Quebec Integrated Chronic Disease Surveillance System (QICDSS) of the Quebec Institute of Public Health to study polypharmacy among older individuals with diabetes, leading to a population-based picture of the situation. By learning more about the types of polypharmacy that are used, it will be possible to guide health professionals to promote optimal drug use.